MedPath

Effect of saffron solution on ulcerative colitis

Early Phase 1
Conditions
lcerative Colitis.
Ulcerative colitis
Registration Number
IRCT20190701044062N5
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients who's disease is diagnosed recently or recent relapce
Patients who can tolerate enema

Exclusion Criteria

Patients with good controlled disease
Patients who can't tolerate enema
Patients with associated disease: Crohn, Intermediate colitis, CMV, Pseudomembrano colitis, Heart failure, Renal failure, PSC

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease activity based on Mayo score. Timepoint: Assessment of disease activity at the beginning of the study and 28 days after the start of saffron enema solution. Method of measurement: Mayo Score.
Secondary Outcome Measures
NameTimeMethod
Frequent defecation. Timepoint: Evaluation of stool frequency at the beginning of the study and 28 days after starting saffron enema solution. Method of measurement: Mayo Score.;Rectal bleeding. Timepoint: Evaluation of rectal bleeding at the beginning of the study and 28 days after starting saffron enema solution. Method of measurement: Mayo score.;Endoscopic findings. Timepoint: Evaluation of endoscopic findings at the beginning of the study and 28 days after starting saffron enema. Method of measurement: Mayo score.
© Copyright 2025. All Rights Reserved by MedPath